The Food and Drug Administration yesterday approved the first generic version of Symbicort, a metered-dose inhaler for asthma and chronic obstructive pulmonary disease.

“Today’s approval of the first generic for one of the most commonly prescribed complex drug-device combination products to treat asthma and COPD is another step forward in our commitment to bring generic copies of complex drugs to the market, which can improve quality of life and help reduce the cost of treatment,” said Sally Choe, director of FDA’s Office of Generic Drugs.
 

Related News Articles

Headline
GE Healthcare is recalling 4,222 backup batteries for its CARESCAPE R860 ventilator in the United States because the batteries may fail before expected,…
Headline
AirBoss Defense Group recently notified customers that certain FlexAir Powered Air Purifying Respirators supplied to the Federal Emergency Management…
Headline
Philips Respironics is recalling all V60 and V60 Plus ventilators because an internal power fluctuation may cause the ventilator to shut down unintentionally,…
Headline
Atrium Medical Corporation has recalled the iCast Covered Stent System due to reports of separation of the balloon or catheter hub separation when removed from…
Headline
Fresenius Kabi USA Monday recalledseven lots of sodium acetate injection after finding particulate matter in sample vials, which could cause infection or other…
Headline
B. Braun Medical Inc. has recalled five lots of 0.9% sodium chloride for injection due to fluid leakage or low fill volume, which could pose an infection risk…